The year in cardiology: arrhythmias and pacing. [PDF]
, 2020 During this last year, there has been much progress with regard to anticoagulant and ablation therapy for atrial fibrillation (AF). Apart from recently issued European Society of Cardiology Guidelines for the management of patients with supraventricular ...
Calkins, H +4 more
core +4 more sources
Ischaemic Supraventricular Tachycardia: A Rare Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2023 The incidence of supraventricular arrhythmias other than Atrial Fibrillation (AF) and atrial flutter in postmyocardial Infarction (MI) patients is usually rare. The incidence of in-hospital AF after MI ranges from 5%-18%.
VE DHANDAPANI +4 more
doaj +1 more source
Cardiac arrhythmias in patients with bronchial asthma
Медицинский совет, 2022 Introduction. According to modern data, bronchial asthma (BA) is an independent risk factor for the development of cardiac arrhythmias (CA), and the use of long-acting β2-agonists (LABA) in basic therapy may further increase the risks of CA.Aim. To study
O. M. Uryasev +4 more
doaj +1 more source
Left Atrial Thrombus in a Neonate with Normal Heart after Sustained Supraventricular Tachycardia [PDF]
Journal of Clinical and Diagnostic Research, 2014 Left Atrial Thrombus is uncommon in neonates. We present a neonate who had Paroxysmal Supraventricular Tachycardia (PSVT), whose echocardiography revealed a large left atrial thrombus which resolved later with treatment.
Amirtha Ganesh B, Ravi Cherian Mathew
doaj +1 more source
PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES) [PDF]
Acta Medica Iranica, 1986 Propafenone HCI (p), is a relatively new Class IC antiarrhythmic agent. It has been reported to be superior to conventional antiarrhythmics in the control of supraventricular, ventricular and WPW associated tachyarrhythmias.
IRAJ NAZERY +1 more
doaj +1 more source
Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. [PDF]
, 2017 Aims: To conduct a randomized trial in order to guide the optimum therapy of symptomatic atrioventricular nodal re-entrant tachycardia (AVNRT).
Camm, AJ +7 more
core +1 more source
Paroxysmal supraventricular tachycardia in pregnancy: A case report
Bali Journal of Anesthesiology, 2023 Paroxysmal supraventricular tachycardia (PSVT) is a clinical syndrome characterized by regular tachycardia with sudden onset and termination that includes atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT),
Andrianto Andrianto +3 more
doaj +1 more source
Zero‐fluoroscopy ablation for cardiac arrhythmias: A single‐center experience in Japan
Journal of Arrhythmia, 2021 Background Exposure to radiation during catheter ablation procedures poses a risk to the heath of both the patient and electrophysiology laboratory staff.
Tohru Kawakami +14 more
doaj +1 more source
Electrocardiographic patch devices and contemporary wireless cardiac monitoring. [PDF]
, 2015 Cardiac electrophysiologic derangements often coexist with disorders of the circulatory system. Capturing and diagnosing arrhythmias and conduction system disease may lead to a change in diagnosis, clinical management and patient outcomes.
Carlson, SK +9 more
core +2 more sources
Emergency cesarean delivery in a parturient who had an intractable paroxysmal supraventricular tachycardia -A case report- [PDF]
Korean Journal of Anesthesiology, 2012 Paroxysmal supraventricular tachycardia (SVT) is a common arrhythmia in the parturient and can occur with or without an underlying organic heart disease.
Kyoung Ok Kim +3 more
doaj +1 more source